Literature DB >> 10389925

Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.

B J Dave1, M M Hess, D L Pickering, D H Zaleski, A L Pfeifer, D D Weisenburger, J O Armitage, W G Sanger.   

Abstract

We studied 850 consecutive cases of histologically ascertained pretreatment non-Hodgkin's lymphoma with cytogenetically abnormal clones. The diagnostic karyotypes revealed that 12% of these cases exhibited structural rearrangements involving chromosome band 1p36. Here, we describe the karyotypes of 53 cases containing a 1p36 rearrangement [often involving translocations of unknown material and presented as add(1)(p36)]. We used fluorescence in situ hybridization to determine the origin of the translocation partners. We report three different recurrent translocations involving 1p36. These include der(1)t(1;1)(p36;q21) (three cases), der(1)t(1;1)(p36;q25) (three cases), and der(1)t(1;9)(p36;q13) (four cases). Using cytogenetic and fluorescence in situ hybridization analyses, we have resolved the translocation partners in 31 cases. Rearrangements of band 1p36 were found among different histopathological subtypes. Alterations of 1p36 never occurred as a sole abnormality, and in 42 of 53 cases, alterations of the band 14q32 were observed. The t(14;18)(q32;q21) translocation was present in 35 cases. The significantly high occurrence of 1p36 breakpoint in structural rearrangements and its involvement in recurrent translocations suggest that the region is bearing gene(s) that are important in lymphomagenesis. Our study also showed that cytogenetically evident deletions were frequent in chromosome 1p, almost always involving the p36 region, whereas duplications were rare and never encompassed the p36 region. Chromosome band 1p36 harbors many candidate tumor suppressor genes, and we propose that one or more of these genes might be deleted or functionally disrupted as a molecular consequence of the rearrangements, thus contributing to lymphomagenesis.

Entities:  

Mesh:

Year:  1999        PMID: 10389925

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  6 in total

1.  Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma.

Authors:  Hesham M Hassan; Michelle L Varney; Smrati Jain; Dennis D Weisenburger; Rakesh K Singh; Bhavana J Dave
Journal:  Leuk Lymphoma       Date:  2014-05-06

2.  Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status.

Authors:  Hesham M Hassan; Michelle L Varney; Nagendra K Chaturvedi; Shantaram S Joshi; Dennis D Weisenburger; Rakesh K Singh; Bhavana J Dave
Journal:  Leuk Lymphoma       Date:  2016-04-13

3.  Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.

Authors:  Imran N Siddiqi; Julia Friedman; Keegan Q Barry-Holson; Charles Ma; Venkata Thodima; Irene Kang; Raghavendra Padmanabhan; Lizalynn M Dias; Kevin R Kelly; Russell K Brynes; Sitharthan Kamalakaran; Jane Houldsworth
Journal:  Mod Pathol       Date:  2016-03-11       Impact factor: 8.209

4.  Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.

Authors:  Francois P Duhoux; Geneviève Ameye; Virginie Lambot; Christian Herens; Frédéric Lambert; Sophie Raynaud; Iwona Wlodarska; Lucienne Michaux; Catherine Roche-Lestienne; Elise Labis; Sylvie Taviaux; Elise Chapiro; Florence Nguyen-Khac; Florence Nguyen Khac; Stéphanie Struski; Sophie Dobbelstein; Nicole Dastugue; Eric Lippert; Frank Speleman; Nadine Van Roy; An De Weer; Katrina Rack; Pascaline Talmant; Steven Richebourg; Francine Mugneret; Isabelle Tigaud; Marie-Joëlle Mozziconacci; Sophy Laibe; Nathalie Nadal; Christine Terré; Jeanne-Marie Libouton; Anabelle Decottignies; Miikka Vikkula; Hélène A Poirel
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

5.  t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.

Authors:  Keni Gu; Kai Fu; Smrati Jain; Zhongfen Liu; Javeed Iqbal; Min Li; Warren G Sanger; Dennis D Weisenburger; Timothy C Greiner; Patricia Aoun; Bhavana J Dave; Wing C Chan
Journal:  Mod Pathol       Date:  2009-05-22       Impact factor: 7.842

6.  Cloning, expression, purification and crystallization of the PR domain of human retinoblastoma protein-binding zinc finger protein 1 (RIZ1).

Authors:  Wanpeng Sun; C Ronald Geyer; Jian Yang
Journal:  Int J Mol Sci       Date:  2008-06-02       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.